Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to ...

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Invasive bladder cancer can be treated through immunotherapy involving Bacillus Calmette-Guérin (BCG), but some 40%-60% of ...

KAIST (President Kwang Hyung Lee) announced on July 1 that a research team led by Professor Heung Kyu Lee of the Department ...

Approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the injectable will cut down on immunotherapy ...

According to the latest study from BCC Research, the "Cancer Immunotherapy: Technologies and Global Markets" is expected to ...

Dr. Brad Nelson has been named B.C. Cancer Victoria’s Lynda and Murray Farmer Immunotherapy Research Chair, which means he ...

Elevated NLR may no longer predict poor survival outcomes in patients with small cell lung cancer (SCLC) receiving ...

NASHVILLE, Tenn. (WTVF) — June is Cancer Immunotherapy Month. Immunotherapy drugs have been on the market for more than a decade. Dr. David Spigel is a medical oncologist at the Sarah Cannon Research ...

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...